KRRO
Korro Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.35
−12.29%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.25
- Revenue estimate
- $187.5K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.07
- EPS estimate
- -$1.34
- Revenue actual
- $1.5M
- Revenue estimate
- $214.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -29.0%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $15
- PT range
- $15 – $15
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.34 | -$1.07 | Beat 20.15% | $1.5M |
| May 7, 2026 | -$1.60 | -$1.69 | Miss -5.62% | — |
| Mar 12, 2026 | -$2.07 | -$5.32 | Miss -156.97% | $1.3M |
| Nov 12, 2025 | -$2.61 | -$1.92 | Beat 26.44% | $1.1M |
| Aug 12, 2025 | -$2.54 | -$2.74 | Miss -7.87% | $1.5M |
| May 7, 2025 | -$2.60 | -$2.49 | Beat 4.23% | $2.5M |
| Mar 18, 2025 | -$2.33 | -$2.26 | Beat 3.00% | $2.3M |
| Aug 13, 2024 | -$2.40 | -$2.43 | Miss -1.25% | — |
| Mar 29, 2024 | -$2.36 | -$26 | Miss -986.86% | — |
| Nov 2, 2023 | -$18 | -$16 | Beat 12.58% | — |
| Aug 10, 2023 | -$0.44 | -$0.30 | Beat 31.82% | — |
| May 12, 2023 | -$0.39 | -$0.55 | Miss -41.03% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026